Abstract
Abnormal placentation is the likely cause of the slow fetal growth and the high levels of circulating lipid peroxides found in severe preeclampsia. These peroxides are probably responsible for the high thromboxane:prostacyclin ratio found in this disease and may participate in the endothelial cell damage which is its most notable feature. Selenium (Se), because of its role in glutathione peroxidase, is suggested to be an important component of the removal system for these damaging peroxides. Serum-Se concentrations have therefore been measured in 19 pairs of pre-eclamptic women and matched controls. Infant birth-weights were recorded. No significant difference was found in the concentrations of Se in pre-eclamptic and control groups. Serum Se was found to be low in both groups. Birthweights were significantly lower in the pre-eclamptic group. The interpretation of serum-Se measurements from the third trimester of a pre-eclamptic pregnancy is complicated by the reduced fetal growth and probable lower Se take-up by the fetus in such a pregnancy. The merits of alternative measurements, such as total intravascular Se, placental Se, or samples from an earlier stage of gestation, are discussed. The importance of factors other than Se to the activity of glutathione peroxidase, and of other antioxidants to pre-eclampsia, is stressed.
Similar content being viewed by others
References
J. M. Roberts, R. N. Taylor, T. J. Musci, G. M. Rodgers, C. A. Hubel, and M. K. McLaughlin, Pre-eclampsia: an endothelial cell disorder.Am. J. Obstet. Gynecol. 161, 1200–1204 (1989).
H. P. Zahradnik, W. Schafer, B. Wetzka, and M. Brockwoldt, Hypertensive disorders in pregnancy,Eicosanoids 4, 123–136 (1991).
R. Arngrimsson, S. Bjornsson, R. T. Geirsson, H. Bjornsson, J. J. Walker, and G. Snaedal, Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population.Br. J. Obstet. Gynaecol. 97, 762–769 (1990).
H. S. Klonoff-Cohen, D. A. Avitz, R. C. Cefalo, and M. F. McCann, An epidemiologic study of contraception and pre-eclampsia.JAMA 252, 3143–3147 (1989).
B. M. Sibai, Immunological aspects of pre-eclampsia,Clin. Obstet. Gynecol. North Am. 34, 27–34 (1991).
W. B. Robertson, I. Brosens, and W. L. Landells, Abnormal Placentation,Obstet. Gynec. Ann. 14, 411–426 (1985).
T. Y. Khong, F. De Wolf, W. B. Robertson, and I. Brosens, Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational-age infants.Br. J. Obstet. Gynaecol. 92, 1049–1059 (1986).
C. W. G. Redman, The placenta and pre-eclampsia,Placenta 12, 301–308 (1991).
D. Wickens, M. H. Wilkins, J. Lunec, G. Ball, and T. L. Dormandy, Free-radical oxidation (peroxidation) products in normal and abnormal pregnancy,Ann. Clin. Biochem. 18, 158–162 (1981).
C. A. Hubel, J. M. Roberts, R. N. Taylor, T. J. Musci, G. M. Rogers, and M. K. McLaughlin, Lipid peroxidation in pre-eclampsia: new perspectives on pre-eclampsia,Am. J. Obstet. Gynecol..161, 1025–1034 (1989).
J. M. Roberts, R. N. Taylor, and A. Goldfien, Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome pre-eclampsia,Am. J. Hypertension 4, 700–708 (1991).
J. A. Salmon, D. R. Smith, R. J. Flower, S. Moncada, and J. R. Vane, Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes,Biochim. Biophys. Acta 523, 250–262 (1978).
J. Turk, A. Wycke, and P. Needleman, Inactivation of vascular prostacyclin synthetase.Biochem. Biophys. Res. Commun. 95, 1628–1634 (1980).
S. Moncada and J. R. Vane, inBiochemical Aspects of Prostaglandins and Thromboxanes, N. Kharaschand J. Fried, eds., Academic, New York, p. 155 (1977).
N. W. Schoene, V. C. Morris, and O. A. Levander, Effects of selenium deficiency on arachidonic acid metabolism and aggregation in rat platelets, inProstaglandins, Leukotrienes and Lipoxins, J. Martin Bailey, ed., Plenum, New York, pp. 379–385 (1985).
S. W. Walsh, Pre-eclampsia: an imbalance in placental prostacyclin and thromboxane production,Am. J. Obstet. Gynecol. 152, 335–40 (1985).
G. Chen, R. Wilson, G. Cumming, J. J. Walker, W. Ewen Smith, and J. H. Mc Killop, Prostacyclin, thromboxane and antioxidant levels in pregnancy-induced hypertension,Eur. J. Obstet. Gynecol. Reprod. Biol. 50, 243–250 (1993).
Y. Wang, S. W. Walsh, J. Guo, and J. Zhang. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood.Am. J. Obstet Gynecol. 165, 1695–1700 (1991).
M. S. Mikhail, A. Anyaegbunam, D. Garfinkel, P. R. Palan, J. Basu, and S. L. Romney, Pre-eclampsia and antioxidant nutrients: Decreased plasma levels of reduced ascorbic acid, α-tocopherol, and beta-carotene in women with pre-eclampsia.Am. J. Obstet. Gynecol. 171, 150–157 (1994).
K. Kisters, C. Spieker, I. Fafera, M. Tepel, C. Muller, K. H. Rahn, and W. Zidek, Copper, zinc and plasma and intracellular magnesium concentrations in pregnancy and pre-eclampsia.Tr. Elem. Med. 10, 158, (1993).
R. W. Bryant and J. M. Bailey, Altered lipoxygenase metabolism and decreased glutathione peroxidase acctivity in platelets from selenium-deficient rats,Biochem. Biophys. Res. Commun. 92, 268–276 (1980).
Y. Wang, S. W. Walsh, and H. H. Kay, Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with pre-eclampsia,Am. J. Obstet. Gynecol. 167, 946–949 (1992).
P. L. Ogburn Jr., S. Maynard, P. Williams, G. James, S. Johnson, and R. Holman, Arachiodonic acid metabolism and pre-eclampsia,Tenth World Congress of Gynecology and Obstetrics Abstracts, San Francisco, California, October 17–22, 89 (1982).
S. W. Walsh and V. M. Parisi, The role of arachidonic acid metabolites in preeclampsia,Semin. Perinatol. 10, 334–355 (1986).
R. W. Bryant, T. C., Simon, and J. M. Bailey, Hydroperoxy fatty acid formation in selenium-deficient rat platelets: coupling of glutathione peroxidase to the lipoxygenase pathway.Biochem. Biophys. Res. Commun.,117, 183–189 (1983).
R. Schiavon, G. E. Freeman, G. C. Guidi, G. Perona, M. Zatti, and V. V. Kakkar, Selenium enhances prostacyclin production by cultured endothelial cells: possible explanation for increased bleeding times in volunteers taking selenium as a dietary supplement,Thromb Res 34, 389–396 (1984).
S. W. Walsh and Y. Wang, Deficient glutathione peroxidase activity in pre-eclampsia is associated with increased placental production of thromboxane and lipid peroxides,Am. J. Obstet. Gynecol. 169, 1456–61 (1993).
L. Han and S. M. Zhou, Selenium supplement in the prevention of pregnancy induced hypertension,Chin. Med. J. Engl. 107, 870–871 (1994).
A. T. Diplock, Indexes of selenium status in human populations.Am. J. Clin. Nutr. Suppl. 57, 256S-258S (1993).
D. J. Pearson, J. P. Day, V. J. Suarez-Mendez, P. F. Miller, S. Owen, and A. Woodcock, Human selenium status and glutathione peroxidase activity in north-west England,Eur. J. Clin. Nutr. 44, 277–283 (1990).
A. MacPherson, R. Scott, M. N. I. Barclay, and J. Dixon. Plasma selenium concentration of the Scottish population in decline.Proc. Nutr. Soc. 53, 262a (1994).
J. A. Butler, P. D. Whanger, and M. J. Tripp, Blood selenium and glutathione peroxidase activity in pregnant women: comparative assays in primates and other animals,Am. J. Clin. Nutr. 36, 15–23 (1982).
J. Neve, Methods in determination of selenium status,J. Trace Elements Electrolytes Health Dis. 5, 1–17 (1991).
D. Behne and W. Wolters, Selenium content and glutathione peroxidase activity in the plasma and erythrocytes of non-pregnant and pregnant women.J. Clin. Chem. Clin. Biochem. 17, 133–135 (1979).
B. A. Zachara C. Wardak, W. Didlowski, A. Maciag, and E. Marchaluk, Changes in blood selenium and glutathione concentrations and glutathione peroxidase activity in human pregnancy,Gynecol. Obstet. Invest. 35, 12–17 (1993).
G. Peiker, B. Müller, H. Dawezynski, and K. Winnefeld, Selenium in serum and erythrocytes in normal and risk pregnancy (pregnancy-induced hypertension, fetal retardation and hepatosis),Zent. Bl. Gynäkol. 113, 45–48 (1991).
M. P. Rayman, F. R. Abou-Shakra, and N. I. Ward, Determination of selenium in blood serum by hydride generation inductively coupled mass spectrometry,J. Anal. At. Spectrom. 11, 61–68 (1996).
Yudkin, Aboualfa, Eyre, Redman, and Wilkinson,Oxford Standards, Castlemead, Ware, Herts. UK (1987).
A. Kauppila, L. Viinikka, U. M. Makila, E. Yrjanheikki, and H. Korpela, Relationship of serum selenium and lipid peroxidation in preeclampsia, inSelenium in Biology and Medicine, 3rd International Symposium, Beijing, China, G. F. Combs Jr. J. E. Spallholz, O. A. Levander, and J. E. Oldfield, eds., 107 pp. 996–1001 (1984).
J. Uotila, R. Tuimala, and K. Pyykkö, Erythrocyte glutathione peroxidase activity in hypertensive complications of pregnancy,Gynecol. Obstet. Invest. 29, 259–262 (1990).
G. Peiker, M. Kretzschmar, H. Dawczynski, and B. Müller, Lipid peroxidation in pathologic pregnancy: pregnancy-induced hypertension,Zent. Bl. Gynäkol. 113, 183–188 (1991).
S. A. Friedman, Pre-eclampsia: a review of the role of prostaglandins,Obstet. Gynecol. 71, 122–137 (1988).
J. Neve, Selenium et grossesse,Rev. Fr. Gynecol. Obstet. 85, 29–33 (1990).
J. R. Arthur and G. J. Beckett, New metabolic roles for selenium,Proc. Nutr. Soc. 53, 615–624 (1994).
J. T. Uotila, R. J. Tuimala, T. M. Aarnio, K. A. Pyykkö, and M. O. Ahotupa, Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy,Br. J. Obstet. and Gynaecol. 100, 270–276 (1993).
J. Uotila, R. Tuimala, K. Pyykkö, and M. Ahotupa, Pregnancy-induced hypertension is associated with changes in maternal and umbilical blood antioxidants.Gynecol. Obstet. Invest. 36, 153–157 (1993).
S. V. Gunko, N. F. Leus, and V. A. Gunko, Status of selenium metabolism in the screening of pregnant women during the second half of pregnancy,Vopr. Med. Khim. 36, 76–78 (1990).
S. Bro, H. Berendtsen, J. Norgaard, A. Host, and P. J. Jorgensen, Serum selenium concentration in maternal and umbelical cord blood. Relation to course and outcome of pregnancy,J. Trace Elem. Health Dis. 2, 165–169 (1988).
C. D. Thomson and M. F. Robinson, Selenium in human health and disease with emphasis on those aspects peculiar to New Zealand.Am. J. Clin. Nutr. 33, 303–323 (1980).
M. N. I. Barclay, A. MacPherson, and J. Dixon, Selenium content of a range of U. K. foods,J. of Food Composition and Analysis 8, 307–318 (1995).
A. MacPherson, M. N. I. Barclay, R. Scott, R. W. S. Yates, J. R. T. Coutts, and B. M. Groden, Change in selenium intake and effet on selenium status of Scottish population 1978–1995,Trace Elem. Exptl. Med. 8, 93 (1995).
G. Lockitch Selenium: clinical significance and analytical concepts,Cri. Rev. Clin. Lab. Sci. 27, 483–541 (1989).
J. R. Arthur, F. Nicol, and G. J. Beckett, Hepatic iodothyronine 5′-deiodinase. The role of selenium,Biochem. J. 272, 537–540 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rayman, M.P., Abou-Shakra, F.R., Ward, N.I. et al. Comparison of selenium levels in pre-eclamptic and normal pregnancies. Biol Trace Elem Res 55, 9–20 (1996). https://doi.org/10.1007/BF02784164
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02784164